Your browser doesn't support javascript.
Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial.
Turrini, G; Purgato, M; Tedeschi, F; Acartürk, C; Anttila, M; Au, T; Carswell, K; Churchill, R; Cuijpers, P; Friedrich, F; Gastaldon, C; Klein, T; Kösters, M; Lantta, T; Nosè, M; Ostuzzi, G; Papola, D; Popa, M; Sijbrandij, M; Tarsitani, L; Todini, L; Uygun, E; Välimäki, M; Walker, L; Wancata, J; White, R G; Zanini, E; van Ommeren, M; Barbui, C.
  • Turrini G; WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
  • Purgato M; Cochrane Global Mental Health, University of Verona, Verona, Italy.
  • Tedeschi F; WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
  • Acartürk C; Cochrane Global Mental Health, University of Verona, Verona, Italy.
  • Anttila M; WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
  • Au T; Department of Psychology, Koc University, Istanbul, Turkey.
  • Carswell K; Faculty of Medicine, Department of Nursing Science, University of Turku, Turku, Finland.
  • Churchill R; Department of Mental Health & Substance Use, World Health Organization, Geneva, Switzerland.
  • Cuijpers P; Department of Mental Health & Substance Use, World Health Organization, Geneva, Switzerland.
  • Friedrich F; Centre for Review and Dissemination, University of York, York, UK.
  • Gastaldon C; Department of Clinical, Neuro, and Developmental Psychology, Amsterdam Public Health Institute, and WHO Collaborating Centre for Research and Dissemination of Psychological Interventions, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Klein T; Clinical Division of Social Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
  • Kösters M; WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
  • Lantta T; Cochrane Global Mental Health, University of Verona, Verona, Italy.
  • Nosè M; Department of Psychiatry II, Ulm University, Günzburg, Germany.
  • Ostuzzi G; Department of Psychiatry II, Ulm University, Günzburg, Germany.
  • Papola D; Faculty of Medicine, Department of Nursing Science, University of Turku, Turku, Finland.
  • Popa M; WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
  • Sijbrandij M; Cochrane Global Mental Health, University of Verona, Verona, Italy.
  • Tarsitani L; WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
  • Todini L; Cochrane Global Mental Health, University of Verona, Verona, Italy.
  • Uygun E; WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
  • Välimäki M; Cochrane Global Mental Health, University of Verona, Verona, Italy.
  • Walker L; Department of Primary Care and Mental Health, University of Liverpool, Liverpool, England.
  • Wancata J; Department of Clinical, Neuro, and Developmental Psychology, Amsterdam Public Health Institute, and WHO Collaborating Centre for Research and Dissemination of Psychological Interventions, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • White RG; Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
  • Zanini E; Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
  • van Ommeren M; Trauma and Disaster, Mental Health, Bilgi University, Istanbul, Turkey.
  • Barbui C; Faculty of Medicine, Department of Nursing Science, University of Turku, Turku, Finland.
Epidemiol Psychiatr Sci ; 31: e39, 2022 Jun 08.
Article in English | MEDLINE | ID: covidwho-1931279
ABSTRACT

AIMS:

As refugees and asylum seekers are at high risk of developing mental disorders, we assessed the effectiveness of Self-Help Plus (SH + ), a psychological intervention developed by the World Health Organization, in reducing the risk of developing any mental disorders at 12-month follow-up in refugees and asylum seekers resettled in Western Europe.

METHODS:

Refugees and asylum seekers with psychological distress (General Health Questionnaire-12 ⩾ 3) but without a mental disorder according to the Mini International Neuropsychiatric Interview (M.I.N.I.) were randomised to either SH + or enhanced treatment as usual (ETAU). The frequency of mental disorders at 12 months was measured with the M.I.N.I., while secondary outcomes included self-identified problems, psychological symptoms and other outcomes.

RESULTS:

Of 459 participants randomly assigned to SH + or ETAU, 246 accepted to be interviewed at 12 months. No difference in the frequency of any mental disorders was found (relative risk [RR] = 0.841; 95% confidence interval [CI] 0.389-1.819; p-value = 0.659). In the per protocol (PP) population, that is in participants attending at least three group-based sessions, SH + almost halved the frequency of mental disorders at 12 months compared to ETAU, however so few participants and events contributed to this analysis that it yielded a non-significant result (RR = 0.528; 95% CI 0.180-1.544; p-value = 0.230). SH + was associated with improvements at 12 months in psychological distress (p-value = 0.004), depressive symptoms (p-value = 0.011) and wellbeing (p-value = 0.001).

CONCLUSIONS:

The present study failed to show any long-term preventative effect of SH + in refugees and asylum seekers resettled in Western European countries. Analysis of the PP population and of secondary outcomes provided signals of a potential effect of SH + in the long-term, which would suggest the value of exploring the effects of booster sessions and strategies to increase SH + adherence.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Refugees / Stress Disorders, Post-Traumatic / Psychological Distress / Mental Disorders Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: Epidemiol Psychiatr Sci Year: 2022 Document Type: Article Affiliation country: S2045796022000269

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Refugees / Stress Disorders, Post-Traumatic / Psychological Distress / Mental Disorders Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: Epidemiol Psychiatr Sci Year: 2022 Document Type: Article Affiliation country: S2045796022000269